OA11154A - Crystalline hydrated sodium salt of (E)-4,6-dichloro-3-(2-oxo-1-phenylpyrrolidin-3-ylidene methyl)-1H-indole-2-carboxylic acid - Google Patents
Crystalline hydrated sodium salt of (E)-4,6-dichloro-3-(2-oxo-1-phenylpyrrolidin-3-ylidene methyl)-1H-indole-2-carboxylic acid Download PDFInfo
- Publication number
- OA11154A OA11154A OA9900201A OA9900201A OA11154A OA 11154 A OA11154 A OA 11154A OA 9900201 A OA9900201 A OA 9900201A OA 9900201 A OA9900201 A OA 9900201A OA 11154 A OA11154 A OA 11154A
- Authority
- OA
- OAPI
- Prior art keywords
- crystalline hydrated
- compound
- hydrated form
- application
- sodium
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Neurology (AREA)
- Veterinary Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyrrole Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9704498.6A GB9704498D0 (en) | 1997-03-05 | 1997-03-05 | Chemical compound |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| OA11154A true OA11154A (en) | 2003-04-16 |
Family
ID=10808697
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| OA9900201A OA11154A (en) | 1997-03-05 | 1999-09-02 | Crystalline hydrated sodium salt of (E)-4,6-dichloro-3-(2-oxo-1-phenylpyrrolidin-3-ylidene methyl)-1H-indole-2-carboxylic acid |
Country Status (29)
| Country | Link |
|---|---|
| EP (1) | EP0966463A1 (id) |
| JP (1) | JP2001513796A (id) |
| KR (1) | KR20000075907A (id) |
| CN (1) | CN1249750A (id) |
| AP (1) | AP9901637A0 (id) |
| AR (1) | AR011178A1 (id) |
| AU (1) | AU6825198A (id) |
| BG (1) | BG103779A (id) |
| BR (1) | BR9808305A (id) |
| CA (1) | CA2282851A1 (id) |
| CO (1) | CO4940415A1 (id) |
| EA (1) | EA199900710A1 (id) |
| EE (1) | EE9900387A (id) |
| GB (1) | GB9704498D0 (id) |
| HR (1) | HRP980114A2 (id) |
| HU (1) | HUP0002109A2 (id) |
| ID (1) | ID24207A (id) |
| IL (1) | IL131489A0 (id) |
| IS (1) | IS5166A (id) |
| NO (1) | NO994303L (id) |
| NZ (1) | NZ337315A (id) |
| OA (1) | OA11154A (id) |
| PE (1) | PE51399A1 (id) |
| PL (1) | PL335652A1 (id) |
| SK (1) | SK119699A3 (id) |
| TR (1) | TR199902117T2 (id) |
| WO (1) | WO1998039327A1 (id) |
| YU (1) | YU43499A (id) |
| ZA (1) | ZA981791B (id) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9704499D0 (en) * | 1997-03-05 | 1997-04-23 | Glaxo Wellcome Spa | Method of manufacture |
| GB9825988D0 (en) * | 1998-11-27 | 1999-01-20 | Pfizer Ltd | Indole derivatives |
| GB9915231D0 (en) | 1999-06-29 | 1999-09-01 | Pfizer Ltd | Pharmaceutical complex |
| US9737531B2 (en) | 2012-07-12 | 2017-08-22 | Glytech, Llc | Composition and method for treatment of depression and psychosis in humans |
| WO2018229744A1 (en) | 2017-06-12 | 2018-12-20 | Glytech Llc. | Treatment of depression with nmda antagonists and d2/5ht2a or selective 5ht2a antagonists |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9321221D0 (en) * | 1993-10-14 | 1993-12-01 | Glaxo Spa | Heterocyclic compounds |
-
1997
- 1997-03-05 GB GBGB9704498.6A patent/GB9704498D0/en active Pending
-
1998
- 1998-03-03 IL IL13148998A patent/IL131489A0/xx unknown
- 1998-03-03 EP EP98913613A patent/EP0966463A1/en not_active Withdrawn
- 1998-03-03 WO PCT/EP1998/001146 patent/WO1998039327A1/en not_active Application Discontinuation
- 1998-03-03 SK SK1196-99A patent/SK119699A3/sk unknown
- 1998-03-03 JP JP53813598A patent/JP2001513796A/ja active Pending
- 1998-03-03 HU HU0002109A patent/HUP0002109A2/hu unknown
- 1998-03-03 YU YU43499A patent/YU43499A/sh unknown
- 1998-03-03 CO CO98011404A patent/CO4940415A1/es unknown
- 1998-03-03 ID IDW990976A patent/ID24207A/id unknown
- 1998-03-03 EE EEP199900387A patent/EE9900387A/xx unknown
- 1998-03-03 AR ARP980100948A patent/AR011178A1/es unknown
- 1998-03-03 PL PL98335652A patent/PL335652A1/xx unknown
- 1998-03-03 TR TR1999/02117T patent/TR199902117T2/xx unknown
- 1998-03-03 AU AU68251/98A patent/AU6825198A/en not_active Abandoned
- 1998-03-03 CN CN98803053A patent/CN1249750A/zh active Pending
- 1998-03-03 PE PE1998000149A patent/PE51399A1/es not_active Application Discontinuation
- 1998-03-03 NZ NZ337315A patent/NZ337315A/en unknown
- 1998-03-03 CA CA002282851A patent/CA2282851A1/en not_active Abandoned
- 1998-03-03 BR BR9808305-8A patent/BR9808305A/pt not_active Application Discontinuation
- 1998-03-03 ZA ZA9801791A patent/ZA981791B/xx unknown
- 1998-03-03 EA EA199900710A patent/EA199900710A1/ru unknown
- 1998-03-03 KR KR1019997007987A patent/KR20000075907A/ko not_active Application Discontinuation
- 1998-03-03 AP APAP/P/1999/001637A patent/AP9901637A0/en unknown
- 1998-03-04 HR HR9704498.6A patent/HRP980114A2/hr not_active Application Discontinuation
-
1999
- 1999-08-27 IS IS5166A patent/IS5166A/is unknown
- 1999-09-02 OA OA9900201A patent/OA11154A/fr unknown
- 1999-09-03 NO NO994303A patent/NO994303L/no not_active Application Discontinuation
- 1999-10-04 BG BG103779A patent/BG103779A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU6825198A (en) | 1998-09-22 |
| CA2282851A1 (en) | 1998-09-11 |
| ZA981791B (en) | 1999-09-03 |
| EA199900710A1 (ru) | 2000-04-24 |
| BG103779A (en) | 2000-06-30 |
| ID24207A (id) | 2000-07-13 |
| HRP980114A2 (en) | 1998-12-31 |
| GB9704498D0 (en) | 1997-04-23 |
| EP0966463A1 (en) | 1999-12-29 |
| CO4940415A1 (es) | 2000-07-24 |
| BR9808305A (pt) | 2000-05-16 |
| PL335652A1 (en) | 2000-05-08 |
| AP9901637A0 (en) | 1999-09-30 |
| TR199902117T2 (xx) | 2000-03-21 |
| JP2001513796A (ja) | 2001-09-04 |
| HUP0002109A2 (hu) | 2001-04-28 |
| NO994303L (no) | 1999-11-03 |
| PE51399A1 (es) | 1999-06-07 |
| KR20000075907A (ko) | 2000-12-26 |
| NZ337315A (en) | 2001-02-23 |
| IL131489A0 (en) | 2001-01-28 |
| EE9900387A (et) | 2000-04-17 |
| CN1249750A (zh) | 2000-04-05 |
| SK119699A3 (en) | 2000-05-16 |
| WO1998039327A1 (en) | 1998-09-11 |
| IS5166A (is) | 1999-08-27 |
| AR011178A1 (es) | 2000-08-02 |
| YU43499A (sh) | 2000-12-28 |
| NO994303D0 (no) | 1999-09-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AP480A (en) | 3-Substituted indole 2-carboxylic acid derivatives. | |
| JP3908248B2 (ja) | Ｈｉｖインテグラーゼ阻害活性を有するヘテロ環化合物 | |
| TW201533042A (zh) | αvβ整合素拮抗劑 | |
| JP2010132688A (ja) | １−４−（５−シアノインドール−３−イル）ブチル−４−（２−カルバモイルベンゾフラン−５−イル）ピペラジン塩酸塩の多形相 | |
| CN104987321A (zh) | 制造嘧啶衍生物的方法 | |
| WO2013004190A1 (zh) | 胺基丙二醇类衍生物、其制备方法和其药物组合物与用途 | |
| JPH09503770A (ja) | Ｎｍｄａアンタゴニストとしてのインドール誘導体 | |
| KR20240027877A (ko) | 2,4,6-트리플루오로-n-[6-(1-메틸-피페리딘-4-카르보닐)-피리딘-2-일]-벤즈아미드헤미숙시네이트의 대규모 제조를 위한 방법 및 중간체, 및 2,4,6-트리플루오로-n-[6-(1-메틸-피페리딘-4-카르보닐)-피리딘-2-일]-벤즈아미드 아세테이트의 제조 | |
| OA11154A (en) | Crystalline hydrated sodium salt of (E)-4,6-dichloro-3-(2-oxo-1-phenylpyrrolidin-3-ylidene methyl)-1H-indole-2-carboxylic acid | |
| TW201713661A (zh) | 化合物 | |
| JP2001518901A (ja) | キノリン−２−カルボン酸誘導体およびその興奮性アミノ酸拮抗薬としての使用 | |
| CA2393303C (en) | Meglumine salt of a specific quinolinecarboxylic acid compound | |
| CN113788835B (zh) | 一种含吗啉和喹啉环的三唑并四嗪类化合物及其制备方法和应用 | |
| WO2013030374A1 (en) | Novel crystal form | |
| US20240092780A1 (en) | Adducts and dimer compounds synthesized using gk method | |
| CZ314799A3 (cs) | Krystalická hydratovaná sodná sůl kyseliny (E)-4,6-dichlor-3-(2-oxo-l-fenylpyrrolidin-3- ylidenmethyl)-lH-indol-2-karboxylové | |
| TW202136243A (zh) | Zeste增強子同源物2抑制劑及其用途 | |
| EP2373628A1 (en) | Novel compounds | |
| KR20030069228A (ko) | 나트륨-수소 교환물질 1형 억제제의 에탄올레이트 |